| L01FF06 |
L01FF06 Cemiplimab |
| L01FF07 |
L01FF07 Dostarlimab |
| L01FF08 |
L01FF08 Prolgolimab |
| L01FF09 |
L01FF09 Tislelizumab |
| L01FF10 |
L01FF10 Retifanlimab |
| L01FF11 |
L01FF11 Sugemalimab |
| L01FF12 |
L01FF12 Serplulimab |
| L01FF13 |
L01FF13 Toripalimab |
| L01FG |
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors |
| L01FG01 |
L01FG01 Bevacizumab |
| L01FG02 |
L01FG02 Ramucirumab |
| L01FX |
L01FX Other monoclonal antibodies and antibody drug conjugates |
| L01FX01 |
L01FX01 Edrecolomab |
| L01FX02 |
L01FX02 Gemtuzumab ozogamicine |
| L01FX03 |
L01FX03 Catumaxomab |
| L01FX04 |
L01FX04 Ipilimumab |
| L01FX05 |
L01FX05 Brentuximab vedotin |
| L01FX06 |
L01FX06 Dinutuximab beta |
| L01FX07 |
L01FX07 Blinatumomab |
| L01FX08 |
L01FX08 Elotuzumab |
| L01FX09 |
L01FX09 Mogamulizumab |
| L01FX10 |
L01FX10 Olaratumab |
| L01FX11 |
L01FX11 Bermekimab |
| L01FX12 |
L01FX12 Tafasitamab |
| L01FX13 |
L01FX13 Enfortumab vedotin |
| L01FX14 |
L01FX14 Polatuzumab vedotin |
| L01FX15 |
L01FX15 Belantamab mafodotin |
| L01FX16 |
L01FX16 Oportuzumab monatox |
| L01FX17 |
L01FX17 Sacituzumab govitecan |
| L01FX18 |
L01FX18 Amivantamab |